Profiles of pregabalin and gabapentin abuse by postmortem toxicology

被引:104
作者
Hakkinen, Margareeta [1 ]
Vuori, Erkki [1 ]
Kalso, Eija [2 ,3 ]
Gergov, Merja [1 ]
Ojanpera, Ilkka [1 ]
机构
[1] Univ Helsinki, Hjelt Inst, Dept Forens Med, FI-00014 Helsinki, Finland
[2] Univ Helsinki, Inst Clin Med, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Pain Clin, Helsinki, Finland
关键词
Pregabalin; Gabapentin; Drug abuse; Postmortem toxicology; Fatal poisoning; Blood drug concentration; DEPENDENCE; OVERDOSE; ALCOHOL; MISUSE; HPLC;
D O I
10.1016/j.forsciint.2014.04.028
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
030101 [法学理论]; 030111 [法律史学]; 100218 [急诊医学];
摘要
Pregabalin (PRG) and gabapentin (GBP) are used in the treatment of neuropathic pain and epilepsy, and PRG also in generalized anxiety disorder. There is increasing evidence that PRG possesses considerable abuse potential. PRG may have a higher addiction potential than GBP due to its rapid absorption and faster onset of action. Our objective is to estimate the proportion of all PRG- and GBP-related fatalities attributable to PRG and GBP abuse. We investigated all medico-legal death cases in Finland in which PRG or GBP was found in postmortem toxicology during 2010-2011. PRG was found in 316 cases and GBP in 43 cases. Drug abuse was associated with 48.1% of the PRG and 18.6% of the GBP findings. PRG poisoning accounted for 10.1% of all PRG cases and GBP poisoning for 4.7% of all GBP cases. In the drug abuser cases, PRG poisoning represented 19.1%, and GBP poisoning 12.5%. The median blood concentration of PRG was 15 mg/L in the abuser group and 5.8 mg/L in the other cases. For GBP, these concentrations were 12 mg/L and 8.3 mg/L, respectively. In the PRG abuser group, 91.4% of cases showed concomitant opioid use, while in the rest of these cases neither alcohol nor opioids were detected, but other central nervous system acting drugs were found in each abuser case. In the GBP abuser group, 87.5% of cases showed concomitant opioid use. PRG abuse with high doses is increasingly common and can be fatal when combined with opioids. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 33 条
[1]
Bandelow Borwin, 2007, Expert Rev Neurother, V7, P769, DOI 10.1586/14737175.7.7.769
[2]
Analysis of pregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLC [J].
Berry, D ;
Millington, C .
THERAPEUTIC DRUG MONITORING, 2005, 27 (04) :451-456
[3]
Pregabalin: An antiepileptic agent useful for neuropathic pain [J].
Blommel, Matthew L. ;
Blommel, Amy L. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (14) :1475-1482
[4]
A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin [J].
Bockbrader, Howard N. ;
Wesche, David ;
Miller, Raymond ;
Chapel, Sunny ;
Janiczek, Nancy ;
Burger, Paula .
CLINICAL PHARMACOKINETICS, 2010, 49 (10) :661-669
[5]
Self-poisoning with lamotrigine and pregabalin [J].
Braga, A. J. ;
Chidley, K. .
ANAESTHESIA, 2007, 62 (05) :524-527
[6]
Possible heart failure associated with pregabalin use: case report [J].
Erdogan, Gulay ;
Ceyhan, Dilek ;
Gulec, Sacit .
AGRI-THE JOURNAL OF THE TURKISH SOCIETY OF ALGOLOGY, 2011, 23 (02) :80-83
[7]
Filipetto FA, 2010, J AM OSTEOPATH ASSOC, V110, P605
[8]
Pregabalin abuse and dependence in Germany: results from a database query [J].
Gahr, Maximilian ;
Freudenmann, Roland. W. ;
Hiemke, Christoph ;
Koelle, Makus A. ;
Schoenfeldt-Lecuona, Carlos .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (06) :1335-1342
[9]
Concerns About Pregabalin: Further Experience With Its Potential of Causing Addictive Behaviors [J].
Gahr, Maximilian ;
Franke, Beate ;
Freudenmann, Roland W. ;
Koelle, Markus A. ;
Schoenfeldt-Lecuona, Carlos .
JOURNAL OF ADDICTION MEDICINE, 2013, 7 (02) :147-149
[10]
Pregabalin abuse among opiate addicted patients [J].
Grosshans, Martin ;
Lemenager, Tagrid ;
Vollmert, Christian ;
Kaemmerer, Nina ;
Schreiner, Rupert ;
Mutschler, Jochen ;
Wagner, Xenija ;
Kiefer, Falk ;
Hermann, Derik .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (12) :2021-2025